Pharus Taiwan, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers. (NCT07182214) | Pharus Taiwan, Inc. | 2024-05-05 |
| OncoSweep Cancer Spotlight and Spectrum Product Line (NCT06261294) | Pharus Taiwan, Inc. | 2023-05-29 |
Track Pharus Taiwan, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.